Study to Evaluate Efficacy and Safety in Chinese Patients with Late Onset Pompe Disease with Alglucosidase Alfa Treatmen

Trial Identifier:	ALGMYL09010
Sponsor:	Genzyme, a Sanofi Company
Start Date:	March 2021
Primary Completion Date:	July 2024
Study Completion Date:	July 2024
Condition:	Pompe Disease

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
China	China, China

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.